RecruitingPhase 4NCT06939959

Evaluating the Efficacy of Topical Insulin for the Restoration of Ocular Surface Interface in Dry Eye Disease.


Sponsor

Khyber Teaching Hospital

Enrollment

126 participants

Start Date

Apr 14, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This is a parallel randomized controlled trial for the treatment of dry eye disease. The main objective is to investigate the efficacy and safety of the use of insulin eye drops in the control of moderate-severe dry eye disease. Topical insulin drops will be compared to artificial tears in improving the ocular surface interface in patients with dry eye disease over 1 year period.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Artificial tear and a drug called insulin human for people with dry eye and insulin sensitivity. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGArtificial tear

commercially available artificial tears will be used consisting of same ingredients.

DRUGinsulin human

injection humulin will be used to make topical insulin drops


Locations(1)

Khyber Teaching Hospital

Peshawar, Khyber Pukhtunkhwa, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06939959


Related Trials